Clinical Trials Browser

HER2-positive Breast Cancer × Fulvestrant × 1 year × Clear all

NCT07179939 2025-09-18

Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

Phase 2 Not yet recruiting

HER2-positive Breast Cancer